283 related articles for article (PubMed ID: 24675282)
1. Mitochondrial DNA disease-molecular insights and potential routes to a cure.
Russell O; Turnbull D
Exp Cell Res; 2014 Jul; 325(1):38-43. PubMed ID: 24675282
[TBL] [Abstract][Full Text] [Related]
2. A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells.
Moraes CT
EMBO Mol Med; 2014 Apr; 6(4):434-5. PubMed ID: 24623377
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.
Gammage PA; Rorbach J; Vincent AI; Rebar EJ; Minczuk M
EMBO Mol Med; 2014 Apr; 6(4):458-66. PubMed ID: 24567072
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA triplication and punctual mutations in patients with mitochondrial neuromuscular disorders.
Mkaouar-Rebai E; Felhi R; Tabebi M; Alila-Fersi O; Chamkha I; Maalej M; Ammar M; Kammoun F; Keskes L; Hachicha M; Fakhfakh F
Biochem Biophys Res Commun; 2016 Apr; 473(2):578-85. PubMed ID: 27033601
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Diseases: Hope for the Future.
Russell OM; Gorman GS; Lightowlers RN; Turnbull DM
Cell; 2020 Apr; 181(1):168-188. PubMed ID: 32220313
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial diseases and ATPase defects of nuclear origin.
Houstek J; Mrácek T; Vojtísková A; Zeman J
Biochim Biophys Acta; 2004 Jul; 1658(1-2):115-21. PubMed ID: 15282182
[TBL] [Abstract][Full Text] [Related]
7. Deregulated Mitochondrial DNA in Diseases.
Nguyen NNY; Kim SS; Jo YH
DNA Cell Biol; 2020 Aug; 39(8):1385-1400. PubMed ID: 31944832
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of engineering the mitochondrial genome.
Liu M; Ji W; Zhao X; Liu X; Hu JF; Cui J
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166804. PubMed ID: 37429560
[TBL] [Abstract][Full Text] [Related]
9. Allotopic Expression of ATP6 in Mouse as a Transgenic Model of Mitochondrial Disease.
Dunn DA; Pinkert CA
Methods Mol Biol; 2021; 2277():1-13. PubMed ID: 34080141
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.
Manczak M; Park BS; Jung Y; Reddy PH
Neuromolecular Med; 2004; 5(2):147-62. PubMed ID: 15075441
[TBL] [Abstract][Full Text] [Related]
11. Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes.
Lewis CJ; Dixit B; Batiuk E; Hall CJ; O'Connor MS; Boominathan A
Redox Biol; 2020 Feb; 30():101429. PubMed ID: 31981894
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation.
Finsterer J; Zarrouk-Mahjoub S
Chin Med J (Engl); 2016 Aug; 129(15):1889-90. PubMed ID: 27453249
[No Abstract] [Full Text] [Related]
13. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
Bacman SR; Williams SL; Pinto M; Peralta S; Moraes CT
Nat Med; 2013 Sep; 19(9):1111-3. PubMed ID: 23913125
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial replacement: from basic research to assisted reproductive technology portfolio tool-technicalities and possible risks.
Cree L; Loi P
Mol Hum Reprod; 2015 Jan; 21(1):3-10. PubMed ID: 25425606
[TBL] [Abstract][Full Text] [Related]
15. New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters.
Gajewski CD; Yang L; Schon EA; Manfredi G
Mol Biol Cell; 2003 Sep; 14(9):3628-35. PubMed ID: 12972552
[TBL] [Abstract][Full Text] [Related]
16. Nuclear genetic defects of mitochondrial ATP synthase.
Hejzlarová K; Mráček T; Vrbacký M; Kaplanová V; Karbanová V; Nůsková H; Pecina P; Houštěk J
Physiol Res; 2014; 63(Suppl 1):S57-71. PubMed ID: 24564666
[TBL] [Abstract][Full Text] [Related]
17. A case of mitochondrial diabetes associated with 3243 bp tRNA(Leu(UUR)) mutation with few complications, regardless of 16-year disease duration.
Suzuki Y; Atumi Y; Matsuoka K; Taniyama M; Shigeo O
Diabetes Res Clin Pract; 2005 Sep; 69(3):309-10. PubMed ID: 15913828
[No Abstract] [Full Text] [Related]
18. Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation.
Verny C; Guegen N; Desquiret V; Chevrollier A; Prundean A; Dubas F; Cassereau J; Ferre M; Amati-Bonneau P; Bonneau D; Reynier P; Procaccio V
Mitochondrion; 2011 Jan; 11(1):70-5. PubMed ID: 20656066
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis in patients with neuromuscular disorders: Detection of mitochondrial deletion and double mutations in the MT-ATP6 gene.
Felhi R; Mkaouar-Rebai E; Sfaihi-Ben Mansour L; Alila-Fersi O; Tabebi M; Ben Rhouma B; Ammar M; Keskes L; Hachicha M; Fakhfakh F
Biochem Biophys Res Commun; 2016 Apr; 473(1):61-66. PubMed ID: 26993169
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches.
Kucharczyk R; Zick M; Bietenhader M; Rak M; Couplan E; Blondel M; Caubet SD; di Rago JP
Biochim Biophys Acta; 2009 Jan; 1793(1):186-99. PubMed ID: 18620007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
